For research use only
| Cat No. | ABC-SC0141 |
| Product Type | Human Adult Stem Cells |
| Cell Type | Cardiomyocyte |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Heart |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Cardiomyocytes transdifferentiated from Human Cord Blood derived Stem Cell;
HighQC™ human cardiomyocyte differentiation cells are a highly specialized population generated from human cord blood-derived stem cells through directed differentiation. Morphologically, the differentiated cardiomyocytes exhibit a striated, elongated structure typical of mature cardiac muscle cells and demonstrate spontaneous rhythmic contractility in vitro. They grow in a monolayer under adherent culture conditions and display clear sarcomeric organization. These cells express cardiomyocyte markers, including cardiac troponin T (cTnT), α-actinin, and MYH6. Under defined in vitro induction conditions, they can be directed toward cardiomyocyte subtypes with ventricular-like, atrial-like, and pacemaker-like phenotypes. These cells contain subpopulations exhibiting characteristics of stem cell-derived cardiomyocytes, including iPSC-derived cardiac models, supporting advanced studies in cardiac function and disease modeling. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Human Cardiomyocytes Differentiation, From Human Stem Cell, Human Differentiated Cardiomyocytes, hCM-Diff, Human Stem Cell Derived Cardiomyocytes |
| Species | Human |
| Cat.No | ABC-SC0141 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Cardiomyocyte |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Heart |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Adult Stem Cells |
HighQC™ Human Cardiomyocytes Differentiation From Human Stem Cells offer an in vitro platform for cardiovascular research and preclinical applications. These cells can be used for modeling human cardiac development, electrophysiology, and disease pathogenesis, including inherited cardiomyopathies and arrhythmias. They provide a valuable cellular resource for exploring cardiac repair and cell therapy strategies following myocardial infarction.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Cardiomyocytes are derived from iPSCs generated from newborn and adult female donors.
The iPSCs are generated from human skin fibroblasts using an RNA-based Sendai virus reprogramming system to deliver reprogramming factors
No genetic selection or molecular manipulation–based purification methods are used, minimizing genotoxicity risks. The final product contains >40% iPSC-derived cardiomyocytes, with the remaining population composed of functional cardiac support cells, forming a physiologically relevant mixed preparation.
Yes. These cardiomyocytes are suitable for a wide range of applications, including electrophysiology studies, multi-electrode array (MEA) analysis, high-content imaging, viability and toxicity screening, cardiac disease modeling, and cardiac safety pharmacology.